The Clinical Benefits of Antiretroviral Therapy in Severely Immunocompromised HIV-1-Infected Patients with and without Complete Viral Suppression
Amanda Mocroft(University of Copenhagen), H Trocha(Gdańsk Medical University), Wendy Bannister(The Royal Free Hospital), Aza Rakhmanova(City Clinical Oncology Center), Ole Kirk(University of Copenhagen), Justyna Kowalska(Medical University of Warsaw), Martin Fisher(Northwell Health), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Antonella d'Arminio-Monforte(University of Milan), Peter Reiss(Amsterdam Institute for Global Health and Development), José M. Gatell(Universitat de Barcelona)
Cited by 14
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Treatment for Adult HIV Infection
|JAMA|2006|1k